| Name | Title | Contact Details |
|---|
At MELA Sciences, we design and develop innovative software-driven medical technologies for physician clinical use during the detection of skin cancers at the most curable and cost-effective stages. Our mission is to develop breakthrough medical technologies to improve skin cancer detection and achieve better outcomes for all. We envision a world in which our pioneering innovations will change the way patients think about skin cancer, while providing dermatologists and clinicians with new, effective, non-invasive tools for the earliest detection possible. MELA Sciences conducted the largest, positive prospective study ever done on the melanoma disease, and is the first and only medical technology company to receive both FDA Pre-Market Approval (PMA) for the U.S. and CE Marking certification for the European Union for a device of this nature. The company’s flagship product, MelaFind®, is intended to provide dermatologists with software-driven image analysis of clinically atypical pigmented skin lesions when they choose to obtain additional information to help decide whether to biopsy or not. The FDA has approved MELA Sciences’ MelaFind® Pre-Market Approval application for use in the United States and MELA Sciences has also been granted CE Mark approval for sale of MelaFind® in the European Union.
Neurosurgery and Spine Consultants of East Tennessee is a Knoxville, TN-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
AmeriChoice of New York is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
The Accreditation Council for Graduate Medical Education (ACGME) is a private, non-profit, professional organization responsible for the accreditation of approximately 10,000 residency and fellowship programs and the approximately 800 institutions that sponsor these programs in the United States. Residency and fellowship programs educate approximately 125,000 resident and fellow physicians in 150 specialties and subspecialties. The ACGME`s mission is to improve health care and population health by assessing and advancing the quality of resident physicians` education through accreditation. We imagine a world characterized by: • A structured approach to evaluating the competency of all residents and fellows, • Motivated physician role models leading all graduate medical education programs, • High-quality, supervised, humanistic, clinical educational experience, with customized formative feedback, • Clinical learning environments characterized by excellence in clinical care, safety, and professionalism, • Residents and fellows achieving specialty specific proficiency prior to graduation, • Residents and fellows prepared to become Virtuous Physicians who place the needs and well-being of patients first.
Apria Healthcare is one of the nation`s leading providers of home respiratory services and certain medical equipment, including oxygen therapy, inhalation therapies, sleep apnea treatment, and negative pressure wound therapy. Apria was the first such company to obtain voluntary accreditation from the Joint Commission and has been continuously accredited for more than 25 consecutive years. Apria operates more than 290 service locations throughout the United States and serves more than 2 million patients each year. In many cases, it`s a new beginning for its patients with the chance to return home from the hospital to resume their lives. What makes Apria industry leading is its focus on the patient as well as its employees. The people who work at Apria have passion and a commitment to excellence and we foster that compassion. Apria employees continually enhance their skills, receive training, and exhibit the kind of professionalism that makes Apria a highly effective and knowledgeable resource for our patients and healthcare customers.